180 Life Sciences: Biotech Pivots Into Crypto, Shares Skyrocket? Not So Uncommon
Main Idea
The article discusses the significant rise in the share price of 180 Life Science Corp and provides background on the author, Edmund Ingham, a biotech consultant.
Key Points
1. The share price of 180 Life Science Corp increased by more than 145% in trading today.
2. The article is written by Edmund Ingham, a biotech consultant with experience covering over 1,000 companies.
3. Edmund Ingham leads the investing group Haggerston BioHealth.
4. The author discloses no stock, option, or derivative positions in the mentioned companies within the next 72 hours.
5. The article is published on Seeking Alpha, with a disclaimer that past performance is no guarantee of future results.
Description
Summary 180 Life Sciences Corp. has pivoted from a biotech to an Ethereum treasury, driving a massive stock price surge and a rebrand to ETHZilla. The company raised $425M via PIPE and $156M in convertible notes, using proceeds primarily to acquire ETH, now holding over 82,000 ETH. Peter Thiel's rumored 7.5% stake and a new on-chain yield strategy with Electric Capital have fueled investor enthusiasm and rapid valuation growth. I can think of two other struggling biotechs that have pivoted into ...
Latest News
- Crypto short interest sees mixed response in July2025-08-15 15:13:53
- DeFi Dev purchases $22M SOL, grows treasury to 1.42M SOL2025-08-15 14:15:29
- Hong Kong securities watchdog sets new custody rules for crypto exchanges2025-08-15 13:54:01
- ETHZilla (180 Life Sciences) Pivots To Ethereum Treasury Strategy2025-08-15 13:17:29
- Circle prices 10M share public offering at $130 each2025-08-15 07:19:45